Kaleido Biosciences, Inc. KLDO
Set alert
At close · Oct 30
- YTD
- 0.00%
- 1 year
- 0.00%
- Open
- 0.0001
- Prev close
- 0.0001
- Mkt cap
- 4.26K
- Vol
- 1.05K
- Avg vol
- 932
- EPS
- -2.16
- P/E
- 0.00
- Div yield
- 0.00%
More statistics
- Low
- 0.0001
- High
- 0.0001
- Forward P/E
- -0.06
- Beta
- -0.10
- Short ratio
- 29.34
- Inst. own
- 79.77%
- Dividend
- 0.00
- Ex-div date
- Earnings
- May 3, 2022
- 50-d avg
- 1.15
- 200-d avg
- 3.55
- 1y target
- 22.00
News
8 months ago defenseworld.net
Contrasting Kaleido Biosciences (NASDAQ:KLDO) and Adial Pharmaceuticals (NASDAQ:ADIL)
Adial Pharmaceuticals (NASDAQ: ADIL - Get Free Report) and Kaleido Biosciences (NASDAQ: KLDO - Get Free Report) are both small-cap medical companies, but which is the better investment? We will…
4 years ago pennystocks.com
Best Penny Stocks to Buy? 3 to Watch as Musk Offers $43B for TWTR
Check these three penny stocks out as Musk tries to buy TWTR The post Best Penny Stocks to Buy? 3 to Watch as Musk Offers $43B for TWTR appeared first on Penny Stocks to Buy, Picks, News and…
4 years ago investorplace.com
Dear KLDO Stock Fans, Mark Your Calendars for April 28
Kaleido Biosciences (KLDO) stock is soaring on Wednesday but anyone considering a stake in the company will want to keep an eye on April 28. The post Dear KLDO Stock Fans, Mark Your Calendars for…
4 years ago pennystocks.com
Best Penny Stocks to Buy? 3 to Watch as ATRS Stock Explodes
Here's what you need to know about trading penny stocks on April 13th The post Best Penny Stocks to Buy? 3 to Watch as ATRS Stock Explodes appeared first on Penny Stocks to Buy, Picks, News and…
-
4 years ago benzinga.com
Stocks That Hit 52-Week Lows On Friday
During Friday's morning session, 234 stocks hit new 52-week lows.
4 years ago benzinga.com
Kaleido Biosciences Shares Plunging To 52-Week Low, Read Why
Kaleido Biosciences Inc (NASDAQ: KLDO) has delivered formal notice to voluntarily delist its common stock from NASDAQ as the Company will stop all operations. The Company expects to file a Form 25…
4 years ago zacks.com
ORIC Stock Plunges on Discontinuation of Oncology Candidate
ORIC declines on discontinuation of pipeline candidate ORIC-101 following planned interim analyses of two phase Ib studies.
-
4 years ago benzinga.com
Stocks That Hit 52-Week Lows On Friday
On Friday, 209 companies set new 52-week lows.
4 years ago zacks.com
Here's Why Kaleido Biosciences, Inc. (KLDO) is Poised for a Turnaround After Losing 33.2% in 4 Weeks
Kaleido Biosciences, Inc. (KLDO) has become technically an oversold stock now, which implies exhaustion of the heavy selling pressure on it. This, combined with strong agreement among Wall Street…
-
4 years ago benzinga.com
Stocks That Hit 52-Week Lows On Thursday
On Thursday, 105 stocks hit new 52-week lows.
4 years ago globenewswire.com
Kaleido Biosciences to Present Updated Data of KB295 In Ulcerative Colitis at the 2022 Crohn's and Colitis Congress
LEXINGTON, Mass., Jan. 21, 2022 (GLOBE NEWSWIRE) -- Kaleido Biosciences, Inc. (Nasdaq: KLDO), a clinical-stage biotech company with a differentiated, small-molecule approach to treating inflammatory…
-
4 years ago benzinga.com
Stocks That Hit 52-Week Lows On Tuesday
During Tuesday's morning trading, 87 companies set new 52-week lows.
-
4 years ago benzinga.com
Stocks That Hit 52-Week Lows On Thursday
On Thursday, 615 stocks hit new 52-week lows.
4 years ago zacks.com
Kaleido Biosciences, Inc. (KLDO) Sees Hammer Chart Pattern: Time to Buy?
Kaleido Biosciences, Inc. (KLDO) recently saw a Hammer Chart Pattern which can signal that the stock is nearing a bottom.
5 years ago zacks.com
Here's Why Kaleido Biosciences, Inc. (KLDO) Is a Great 'Buy the Bottom' Stock Now
Kaleido Biosciences, Inc. (KLDO) witnesses a hammer chart pattern, indicating support found by the stock after losing some value lately. This coupled with an upward trend in earnings estimate…
5 years ago zacks.com
Kaleido Biosciences, Inc. (KLDO) Reports Q3 Loss, Misses Revenue Estimates
Kaleido Biosciences, Inc. (KLDO) delivered earnings and revenue surprises of 1.82% and -58.40%, respectively, for the quarter ended September 2021. Do the numbers hold clues to what lies ahead for…
5 years ago zacks.com
Down 23.6% in 4 Weeks, Here's Why Kaleido Biosciences, Inc. (KLDO) Looks Ripe for a Turnaround
Kaleido Biosciences, Inc. (KLDO) is technically in oversold territory now, so the heavy selling pressure might have exhausted. This along with strong agreement among Wall Street analysts in raising…
5 years ago globenewswire.com
Kaleido Biosciences to Participate in the Jefferies Virtual Next Generation IBD Therapeutics Summit
LEXINGTON, Mass., Oct. 12, 2021 (GLOBE NEWSWIRE) -- Kaleido Biosciences, Inc. (Nasdaq: KLDO), a clinical-stage biotech company with a differentiated, small-molecule approach to treating inflammatory…
-
5 years ago benzinga.com
36 Biggest Movers From Yesterday
Gainers Bit Digital, Inc. (NASDAQ: BTBT) shares climbed 36.4% to settle at $10.35 on Tuesday amid an increase in the price of Bitcoin and Ethereum.
5 years ago pennystocks.com
5 Penny Stocks To Watch This Week With Potential Biotech Catalysts
Will upcoming events mean big things for these penny stocks? The post 5 Penny Stocks To Watch This Week With Potential Biotech Catalysts appeared first on Penny Stocks to Buy, Picks, News and…
5 years ago globenewswire.com
Kaleido Biosciences to Host Virtual R&D Presentation to Discuss Clinical Data and Pipeline Advancement on October 5, 2021
Latest data and clinical development plans for KB295 in ulcerative colitis (UC) to be presented
5 years ago globenewswire.com
Kaleido Biosciences to Participate in the Morgan Stanley 19th Annual Virtual Global Healthcare Conference
LEXINGTON, Mass., Sept. 02, 2021 (GLOBE NEWSWIRE) -- Kaleido Biosciences, Inc. (Nasdaq: KLDO), a clinical-stage healthcare company with a differentiated, chemistry-driven approach to targeting the…
5 years ago zacks.com
Kaleido Biosciences, Inc. (KLDO) Reports Q2 Loss, Lags Revenue Estimates
Kaleido Biosciences, Inc. (KLDO) delivered earnings and revenue surprises of 5.08% and -15.60%, respectively, for the quarter ended June 2021. Do the numbers hold clues to what lies ahead for the…
5 years ago globenewswire.com
Kaleido Biosciences Reports Second Quarter 2021 Financial Results
--On track to report topline data from a clinical study of KB295 in patients with mild-to-moderate ulcerative colitis by end of third quarter-- --Kaleido and the COPD Foundation to collaborate on the…
5 years ago globenewswire.com
Kaleido Biosciences and the COPD Foundation Announce a Strategic Collaboration to Advance KB109 into Phase 2 Clinical Trial
On track to initiate Phase 2 trial in the first quarter of 2022 On track to initiate Phase 2 trial in the first quarter of 2022
5 years ago globenewswire.com
Kaleido Biosciences Announces New Chairperson Appointment to its Board of Directors
Current Director Theo Melas-Kyriazi appointed Chairperson of the Board of Directors Current Director Theo Melas-Kyriazi appointed Chairperson of the Board of Directors
-
5 years ago benzinga.com
Stocks That Hit 52-Week Highs On Thursday
On Thursday morning, 92 companies achieved new highs for the year.
-
5 years ago benzinga.com
Stocks That Hit 52-Week Highs On Tuesday
Tuesday's morning session saw 269 companies set new 52-week highs.
-
5 years ago benzinga.com
Stocks That Hit 52-Week Highs On Thursday
Before 10 a.m. ET Thursday, 503 stocks hit new 52-week highs.
-
5 years ago benzinga.com
Stocks That Hit 52-Week Highs On Tuesday
On Tuesday morning, 323 companies hit new 52-week highs.
-
6 years ago benzinga.com
Mid-Morning Market Update: Markets Open Higher; Donaldson Reports Mixed Q3 Results
Following the market opening Tuesday, the Dow traded up 0.67% to 25645.59 while the NASDAQ rose 0.07% to 9558.84. The S&P also rose, gaining 0.32% to 3065.47.
-
6 years ago benzinga.com
96 Biggest Movers From Yesterday
Gainers Mmtec, Inc. (NASDAQ: MTC) shares climbed 86.4% to close at $2.05 on Tuesday after reporting its financial results for the year ended December 31, 2019. Revenues jumped 647% to $200,797, in…
-
6 years ago benzinga.com
36 Stocks Moving In Thursday's Mid-Day Session
36 Stocks Moving In Thursday's Mid-Day Session
-
7 years ago benzinga.com
Stocks That Hit 52-Week Lows On Thursday
Stocks That Hit 52-Week Lows On Thursday
-
7 years ago benzinga.com
54 Stocks Moving In Monday's Mid-Day Session
54 Stocks Moving In Monday's Mid-Day Session
-
7 years ago benzinga.com
List of Companies Reaching Yearly Lows Tuesday
List of Companies Reaching Yearly Lows Tuesday